West Pharmaceutical Services (WST) Revenue — Quarter Ended Dec 31, 2025
Revenue for the quarter was flat sequentially, matching the previous period's level. Compared with the same quarter a year ago, revenue increased.
Key takeaway
Quarter ended Dec 31, 2025 · FY2025 Q4
Revenue for the quarter was flat sequentially, matching the previous period's level. Compared with the same quarter a year ago, revenue increased.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$805M
Revenue reported for this quarter.
Quarter-over-quarter
+0.0%
Change from the immediately preceding quarter.
Year-over-year
+7.5%
Change from the comparable year-ago quarter.
Trailing four quarters
$3.1B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2025 | $698M | +0.4% |
| Jun 30, 2025 | $766.5M | +9.2% |
| Sep 30, 2025 | $804.6M | +7.7% |
| Dec 31, 2025 | $805M | +7.5% |
Revenue performance
The reported revenue was unchanged from the immediately preceding quarter, breaking a trend of sequential growth seen earlier in the fiscal year.
Quarterly comparison
On a year-over-year basis, revenue rose, continuing a pattern of positive annual comparisons. The trailing twelve-month revenue was materially higher than the current quarter's figure.
What to watch
Monitor whether the flat sequential quarter reflects a seasonal pause or the start of a broader trend, given the prior quarters had steady growth.